SkilaMederi (extinct)

SkilaMederi (extinct)

SkilaMederi (extinct)

Date Founded



201 Littleton Road,2nd floor,Morris Plains, NJ 07950

Type of Company



IT Consulting & Services
Advertising & Marketing

Company Description

SkilaMederi provided social analytics and launch management solutions for pharmaceutical industry. The company was founded in 2012 and is headquartered in Morris Plains, NJ.

Paths to SkilaMederi
Potential Connections via
Relationship Science
Recent Transactions
Details Hidden

Qforma, Inc. purchases SkilaMederi from BelHealth Investment Partners LLC

Details Hidden

Sela2, Inc., BelHealth Investment Partners LLC purchase Mederi AG resulting in a new company SkilaMederi

Details Hidden

Former President & Chief Executive Officer at Sela2, Inc.

Details Hidden

BelHealth Investment Partners focuses exclusively on investments in small-cap companies in the healthcare industry. The firm targets undervalued or undermanaged, founder-owned, public or private companies in which their operating experience and resources can drive growth and profitability. BelHealth invests primarily in low to medium technology companies in the healthcare services, healthcare information technology, marketed pharmaceutical and marketed medical products industries.BelHealth looks for companies with enterprise value up to $100 million, revenues of $10 million to $100 million, proforma operating profits near break-even up to $10 million and the potential to improve operating margins. In addition, they seek companies with long-term competitive advantages in attractive potential markets and the potential for profitable exit opportunities within 3 to 5 years. BelHealth targets early growth stage companies with recurring revenue models, low customer concentration, little or no exposure to reimbursement risk, the potential for margin expansion and low operating leverage. The firm does not consider investments in companies that have not yet generated revenue, depend heavily on government reimbursement, market commodity products/services or companies requiring significant capital investment.BelHealth typically invests $10 million to $20 million per company. Investments are generally structured as equity stakes, although BelHealth may also use other structures such as convertible debt to mitigate or minimize risks as appropriate. They may utilize securities with liquidation preferences such as preferred, participating or convertible preferred stock or equity-linked debt. BelHealth employs a limited use of leverage. The firm prefers to make control investments, either through majority ownership and/or board control. BelHealth also prefers to participate in situations in which management retains meaningful ownership and receives compensation packages that reward strong performance.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by SkilaMederi. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of SkilaMederi's profile does not indicate a business or promotional relationship of any kind between RelSci and SkilaMederi.